OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions

le said.

What is being done about this today? Currently marketed antidiarrheal drugs are not safe for use in young children, and there are no approved drugs for children with diarrhea. Most therapies today target the adult travelers' market with little consideration for pediatric use. Some vaccines focus on one pathogen, such as rotavirus, although there are multiple causative pathogens.

Efforts are also underway to prevent exposure to the pathogens responsible for diarrhea in developing countries. However, these require massive improvements in sanitation, hygiene, and nutritional status in developing countries, which are unlikely to have an impact in the short term.

In response, OneWorld Health is pursuing safe, effective, and affordable drug candidates for pediatric diarrhea that will reduce stool output and save babies' lives. A new drug may be used in conjunction with oral rehydration therapy (ORT) in the developing world. ORT is the globally approved treatment for secretory (watery) diarrhea that has been credited with reducing infant mortality by about half. ORT involves giving a dilute solution of sugar and salt orally to children to replace both the water and vital nutrients (electrolytes) lost in diarrhea; it does not treat the diarrhea itself. Parents, out of frustration that ORT does not reduce stool output, purchase antibiotics for their children, which are almost always ineffective and disturb normal intestinal balance.


Contact: Joanne Hasegawa
Institute for OneWorld Health

Page: 1 2

Related biology news :

1. Institute for OneWorld Health nominated for the 2004 World Technology Awards
2. Institute for OneWorld Health receives Gates Foundation grant
3. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
4. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
5. OneWorld Health completes enrollment, treatment in Phase III India trial
6. Institute for OneWorld Health CEO advocates focus first on developing world markets
7. OneWorld Health plans to form network of volunteer pharmaceutical scientists for global health
8. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
9. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
10. Health of worlds sea lions the focus of Wakefield Symposium
11. Healthy fats and oils essential to satisfy calorie-conscious consumers

Post Your Comments:

(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
(Date:7/22/2020)... ... July 21, 2020 , ... ... innovation in technology and compliance, announces a new solution to manage regulated workloads ... every layer of their technology stack complies with FDA and global regulations. USDM's ...
(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is ... ability to discover a COVID cure or vaccine, the global economic downturn will only ... pressure is not going away and capturing full value from every product launch is ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, the ... new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at a ... fast track capacity to provide patients with urgently needed vaccines and other lifesaving ...
(Date:7/31/2020)... ... July 29, 2020 , ... The SDX® Respiratory ... 16 countries, has reached its 20th anniversary of worldwide use. Introduced in the ... top universities including University of Pennsylvania, University of Michigan, University of Maryland, University ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... aid in the early detection and prevention of high-burden diseases, and Centric Consulting, ... hospitals and healthcare organizations to utilize existing data in order to identify and ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien ... announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical ... development of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus ...
Breaking Biology Technology:
Cached News: